IMCD N.V. (“IMCD”), a leading distributor of speciality chemicals and ingredients, has entered into a share purchase agreement on 26 November 2020 to acquire the personal care business of Ejder Kimya İlaç Danışmanlık Sanayi ve Ticaret A.Ş (“Ejder Kimya”). The transaction is expected to close in January 2021, subject to customary closing conditions and regulatory approval.
Paksoy is pleased to announce that a team led by Elvan Aziz (partner) together with Gözde Zorlu (associate) and Simge Şengün (associate) acted as Turkish counsel to IMCD on this transaction.
Share
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
6 March 2026
Paksoy advises on Türkiye Petrolleri’s landmark USD 4 billion Sukuk Programme and inaugural USD 1 billion issuance
Paksoy is pleased to have advised on the establishment of Türkiye Petrolleri’s USD 4 billion Sukuk Issuance Programme and the successful…
27 February 2026
International Women’s Day 2026 – Women at Paksoy
At Paksoy, we believe women are fundamental to our leadership and value creation. Their contribution is not just part of our identity - it…
23 February 2026
Doğuhan Uygun and Pınar Noberi contributed to the Austrian Yearbook on International Arbitration 2026
We are pleased to announce that Doğuhan Uygun, partner, and Pınar Noberi, associate, have contributed to the Austrian Yearbook on…
18 February 2026
Once again, we are recognised among the top-tier in the Chambers Global Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers Global Guide 2026.
16 February 2026
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage.
12 February 2026
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey.
